Worldwide, most individuals affected by FH have a single mutation (heterozygotic) in either the low density lipoprotein receptor (LDLR), apolipoprotein B (APOB), or proprotein convertase subtilisin/kexin type 9 (PCSK9) genes [5]. This evidence concerns the gene LDLR and familial hyperaldosteronism.